BMJ Investigation: Researcher blows the whistle on data integrity issues in Pfizer's vaccine trial

Created on 2022-01-27T01:12:16-06:00

Return to the Index

This card pertains to a resource available on the internet.

This card can also be read via Gemini.

BMJ 10.1136/bmj.n2635

Brook Jason notified Ventavia of failures in quality control and was fired after notifying the FDA.

Needles were not disposed of correctly.

Information was left on documents which allowed staff to violate the blinding of the study.

Management knew of data falsification occuring.

FDA refused to investigate Ventavia and later admitted it did not only checking 9 of 153 testing sites.